Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

Also called NCT05020535

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05020535
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05020535. Randomized; quadruple masking; primary purpose treatment. Start 2022-10-10 (actual); primary completion 2026-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
Acronym
BEACH
Condition
Intracerebral Hemorrhage
Intervention (Drug)
MW189
Intervention (Other)
Saline
Lead sponsor
Johns Hopkins University (class: other)
Collaborator
University of Kentucky (class: other)
Collaborator
National Institute on Aging (NIA) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05020535
Content hash
6137e26532bacaa59444e8098ac7aed10f24903b4eb59f09d1fd82ff7ef7555c